Altered Circulating Biomarkers of Purinergic Signaling, Inflammasome-Related Pathways, Pyroptosis, and Oxidative Stress in Fibromyalgia
International Journal of Molecular Sciences · 24.07.2026 · 27 (15) · 6579
DOI: 10.3390/ijms27156579 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.07.2026. Verfasst von Emrullah Hayta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy and Rehabilitation, Ataşehir Acibadem Hospital, Acibadem University, Istanbul 34758, Türkiye. Hauptthemen laut MEDLINE: Fibromyalgia, Oxidative Stress, Biomarkers, Inflammasomes. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1) Fibromyalgia syndrome (FMS) is a chronic pain disorder with a multifactorial pathogenesis involving neuroinflammation, oxidative stress, and immune dysfunction. This study aimed to evaluate serum biomarkers related to purinergic signaling, inflammasome activation, pyroptosis, and oxidative stress in patients with FMS. (2)
Methods
A total of 93 patients with FMS and 93 age- and sex-matched healthy controls were enrolled. Serum levels of pannexin-1 (PANX1), purinergic receptor P2X7 (P2RX7), NLRP3, caspase-1 (CASP1), interleukin-1β (IL-1β), interleukin-18 (IL-18), gasdermin D (GSDMD), and gasdermin E (GSDME) were measured using enzyme-linked immunosorbent assays (ELISA). (3)
Results
Total antioxidant status (TAS) and total oxidant status (TOS) were determined. Patients with FMS exhibited significantly increased serum CASP1, GSDME, PANX1, P2RX7, and total oxidative stress (TOS) levels, whereas GSDMD, NLRP3, IL-18, and TAS levels were significantly decreased compared with controls (all p < 0.05). No significant differences were observed in IL-1β levels. Receiver operating characteristic analysis demonstrated exploratory discriminatory performance within this case–control cohort for CASP1 and TAS (AUC = 0.898), followed by TOS (AUC = 0.849) and P2RX7 (AUC = 0.757). (4)
Conclusions
These findings indicate alterations in circulating biomarkers related to purinergic signaling, inflammasome-associated pathways, pyroptosis-related proteins, and oxidative stress in patients with FMS. These alterations may contribute to the pathophysiology of FMS and provide a foundation for future mechanistic studies investigating their potential as biomarkers and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Therapy and Rehabilitation, Ataşehir Acibadem Hospital, Acibadem University, Istanbul 34758, Türkiye.
- Department of Food Processing Technologies Services, Yıldızeli Vocational School, Sivas Cumhuriyet University, Sivas 58140, Türkiye.
- Department of Biochemistry, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Türkiye.
ORCID-Profile: Ayca Tas
Zitieren
APA
Hayta, E., Agbektas, T., Kabak, G., Dogan, G., Tas, A., & Silig, Y. (2026). Altered Circulating Biomarkers of Purinergic Signaling, Inflammasome-Related Pathways, Pyroptosis, and Oxidative Stress in Fibromyalgia. International Journal of Molecular Sciences, 27(15), 6579. https://doi.org/10.3390/ijms27156579
Vancouver
Hayta E, Agbektas T, Kabak G, Dogan G, Tas A, Silig Y. Altered Circulating Biomarkers of Purinergic Signaling, Inflammasome-Related Pathways, Pyroptosis, and Oxidative Stress in Fibromyalgia. International Journal of Molecular Sciences. 2026;27(15):6579. doi:10.3390/ijms27156579
BibTeX
@article{Hayta2026,
author = {Hayta, Emrullah and Agbektas, Tugba and Kabak, Gonca and Dogan, Gokhan and Tas, Ayca and Silig, Yavuz},
title = {Altered Circulating Biomarkers of Purinergic Signaling, Inflammasome-Related Pathways, Pyroptosis, and Oxidative Stress in Fibromyalgia},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6579},
doi = {10.3390/ijms27156579}
}
EUVIMED